Literature DB >> 1335038

Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka.

N Takahashi1, S Ueno, T Uemichi, H Fujimura, S Yorifuji, S Tarui.   

Abstract

A Japanese patient with systemic amyloidosis associated with a transthyretin (TTR) variant Arg50 is presented. This 41-year-old man became impotent and developed decreased pain sensation in his hands, and then sensory loss and muscle wasting in his lower legs, and cardiomyopathy appeared. The symptoms progressed and he died of congestive heart failure at age 46. There were amyloid deposits in all organs studied and massive amyloid deposition was seen in the peripheral nerves and cardiac muscles. Amyloid fibrils extracted from heart tissue contained TTR. A genetic mutation, causing a Ser50-->Arg substitution of the TTR molecule, was identified in another family member. Plasma TTR was shown to be a mixture of normal TTR Ser50 and mutant TTR Arg50 in the 2 subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335038     DOI: 10.1016/0022-510x(92)90132-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: a quantitative light and electron microscopic study of the peripheral nervous system.

Authors:  K Toyooka; H Fujimura; S Ueno; H Yoshikawa; M Kaido; T Nishimura; S Yorifuji; T Yanagihara
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases.

Authors:  Alejandra González-Duarte; Karla Cárdenas-Soto; Carlo Enrico Bañuelos; Omar Fueyo; Carolina Dominguez; Benjamín Torres; Carlos Cantú-Brito
Journal:  Orphanet J Rare Dis       Date:  2018-07-03       Impact factor: 4.123

3.  Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.

Authors:  Ole B Suhr; Marie Larsson; Bo-Göran Ericzon; Henryk E Wilczek
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.